Sangamo stock price target

Shares of Sangamo were last seen up about 4% at $11.83, with a 52-week range of $6.26 to $19.25. The consensus analyst price target is $23.50. Shares of Pfizer were recently seen down 1.6% at $43 Sangamo Therapeutics, Inc. (SGMO) Price - Zacks.com Price is a widely used stock evaluation measure. Find the latest Price for Sangamo Therapeutics, Inc. (SGMO) Sangamo Therapeutics, Inc. (SGMO) Price - Zacks.com Sangamo Therapeutics Inc : SGMO Stock Price Quote at Ally ... Free current stock price quotes and data for Sangamo Therapeutics Inc (SGMO). Research news, charts, stock market performance and earnings. Wedbush Cuts Price Target on Sangamo Therapeutics to $10 From $11, Maintains Neutral Rating 6:53AM ET 3/05/2020 MT Newswires. Presentations | Sangamo Therapeutics, Inc.

All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Find the latest Sangamo Therapeutics, Inc. (SGMO) stock quote, history, news and other vital information to help you with your stock trading and investing. Sangamo Therapeutics, Inc. Common Stock (SGMO ... - …

9 Mar 2020 Stocks quotes in this article: SGMO, BIIB president and CEO of Sangamo Therapeutics Inc. (SGMO) , a biotech company whose shares rose

Do Analysts Recommend You Should Buy Sangamo Therapeutics ... Mar 03, 2020 · On Monday, shares of Sangamo Therapeutics, Inc. (NASDAQ:SGMO) marked $8.50 per share versus a previous $8.53 closing price. With having a -0.35% loss, an insight into the fundamental values of Sangamo Therapeutics, Inc., investors would also find a great ally in the technical patterns of the stock movements showed in stock charts. News Releases | Investor Relations | Sangamo Therapeutics ... Stock Information. Historic Price Lookup; Investment Calculator and a neuromuscular target, with exclusive rights for nine additional undisclosed (BUSINESS WIRE)--Feb. 25, 2020-- Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that the Company has scheduled the release of its fourth quarter and Analysts’ Recommendations for Sangamo Therapeutics and ...

Sangamo Therapeutics, Inc. Common Stock (SGMO) Analyst ...

Sangamo Therapeutics Inc. dominated the market today, gaining €0.27 (4.560%). With 8 Buy predictions and not the single Sell prediction the community is currently very high on Sangamo Therapeutics Inc.. Based on the current price of €6.25 the target price of €13.00 shows a potential of 107.867 Earnings Estimates | Sangamo Therapeutics, Inc. The Investor Relations website contains information about Sangamo Therapeutics, Inc.'s business for stockholders, potential investors, and financial analysts. SGMO Stock Price & Charts | Sangamo Therapeutics In depth view into SGMO (Sangamo Therapeutics) stock including the latest price, news, dividend history, earnings information and financials.

Sangamo Therapeutics, Inc. (SGMO) Stock Price, Quote ...

SGMO: Get the latest Sangamo Therapeutics stock price and detailed information including SGMO news, historical charts and realtime prices.